Dermatology Professional

You are now entering the ENBREL.com Health Care Professional website for Dermatologists. This site is intended for US Health Care Professionals only. If you would like to continue, please click the link below.

Yes, I am a US Health Care Professional

Enter Site
For psoriatic arthritis and adult chronic moderate to severe plaque psoriasis

Rheumatology Professional

You are now entering the ENBREL.com Health Care Professional website for Rheumatologists. This site is intended for US Health Care Professionals only. If you would like to continue, please click the link below.

Yes, I am a US Health Care Professional

Enter Site
For moderate to severe rheumatoid arthritis, ankylosing spondylitis, and moderately to severely active juvenile idiopathic arthritis

ENBREL Prior Auth Assist

Verify insurance coverage and submit prior authorizations (PAs) for your patients online. Sign up for ENBREL Prior Auth Assist—one more way to help your patients get the treatment that they need faster.

Go to ENBREL Prior Auth Assist Home

For a complete list of indications, please click here.


 
INDICATIONS

ENBREL is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be initiated in combination with methotrexate (MTX) or used alone.

ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients ages 2 and older.

ENBREL is indicated for reducing signs and symptoms, inhibiting the progression of structural damage of active arthritis, and improving physical function in patients with psoriatic arthritis. ENBREL can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.

ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.

ENBREL is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Announcements

Updated: Important ENBREL Product Information. Learn more